跳至主要内容
临床试验/CTRI/2017/08/009211
CTRI/2017/08/009211招募中3 期

An open clinical trial to evaluate the therapeutic efficacy of siddha herbo mineral formulation of "Ganthaka Rasaayanam"(Internal medicine) and "Vettiver Thylam"(External medicine) for the management of "Kalanjagapadai"(Psoriasis)

National Institute of Siddha1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年11月2日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Good outcome –Clearance of lesions and

研究概览

简要总结

It is a single, non-randomized, open-label trial to determine the efficacy  of GANTHAKA RASAAYANAM (Prepared from herbo mineral constitutents) in patients with

KALANJAGAPADAI (PSORIASIS). In this trial 40 patients will be recruited and the trial drug will

be administered 2 gm twice a day for a period of 40 days. During this trial period all the study

related data will be recorded and documented in a page separate trial master file for

each patients.During the trial period if any AE/SAE/SUSAR will be noticed and referred to

pharmacovigilance dept.in NIS and further management will also be given in NIS OPD/IPD.The

entire trial will be monitored by the research monitoring committee OF NIS.  After completion of the trial all the

study related data will be analysed statistically .The out come of this trial will be published in Indian

Journal of Medical Research

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Erythema 2.Thickness 3.Silvery scaling 4.Auspitz sign positive 5.Candle crease sign positive 6.Patients willing to give specimen of blood for investigation whenever required 7.Patients willing to take photograph 8.Patients willing to participate in the trial and signing consent by fullfilling the condition of proforma.

排除标准

  • 1.Diabetes mellitus 2.Pregnancy and lactation 3.Psoriasis with evidence of any other skin disease or evidence of secondary infection in the lesion 4.Psoriatic arthropathy 5.Cardiac disease 6.Hansens disease 7.Any other chronic illness.

结局指标

主要结局

Good outcome –Clearance of lesions and

时间窗: 40 Days

Reduction of PASI Score from 3,4 to 0,1.

时间窗: 40 Days

Moderate outcome –Partial clearance of lesions

时间窗: 40 Days

and Reduction of PASI Score from 3,4 to 2.

时间窗: 40 Days

Mild- Slight clearancce of lesions and reduction of PASI score from 4 to 3

时间窗: 40 Days

Nil- NO Clearance of lesions or No reduction PASI Score

时间窗: 40 Days

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验